Nuvation Bio Inc. SEC filings NUVB
Nuvation Bio Inc. has 400 filings in SEC EDGAR's recent list, going back to May 15, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 10, 2026 | May 21, 2026 |
| DEF 14A | Proxy statement | Apr 8, 2025 | May 21, 2025 |
| DEF 14A | Proxy statement | Jul 30, 2024 | Sep 3, 2024 |
| PRE 14A | Preliminary proxy statement | May 24, 2024 | Jul 10, 2024 |
| DEF 14A | Proxy statement | Apr 4, 2023 | May 15, 2023 |
| DEF 14A | Proxy statement | Apr 4, 2022 | May 16, 2022 |
Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NUVB (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1811063
- Former names
- Panacea Acquisition Corp (until Feb 11, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.